Format

Send to:

Choose Destination
See comment in PubMed Commons below
Trends Pharmacol Sci. 1990 Mar;11(3):122-6.

Somnogenic activity of immune response modifiers.

Author information

  • 1Department of Physiology and Biophysics, College of Medicine, University of Tennessee Memphis 38163.

Abstract

Sleepiness is a presenting symptom in nearly all infectious diseases. James Krueger describes how microbial products, such as muramyl peptides, lipid A and double-stranded RNA, as well as endogenous products elicited by these substances, such as interleukin 1, modulate sleep. The altered sleep during infection seems to result from an exaggerated activation of physiological sleep mechanisms, since normal sleep is controlled by a wide range of substances including many of these immune response modifiers.

PMID:
2104463
[PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk